查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1870283

抗菌醫用紡織品市場：按產品、最終用戶、材料、技術、應用和分銷管道分類 - 全球預測（2025-2032 年）

Antimicrobial Hospital Textiles Market by Product, End User, Material, Technology, Application, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，抗菌醫院紡織品市場規模將達到 237.4 億美元，複合年成長率為 7.50%。

關鍵市場統計數據
基準年 2024 133億美元
預計年份：2025年 143億美元
預測年份 2032 237.4億美元
複合年成長率 (%) 7.50%

臨床和採購實踐的模式轉移正在推動檢驗的抗菌紡織品在醫院運作和醫療保健環境中廣泛應用。

隨著臨床安全優先事項與營運成本壓力和永續性要求一致，醫院紡織品領域正在經歷持續的變革。抗菌整理和嵌入式技術不再是實驗性的附加功能，而是所有重症監護區域（包括加護病房、病房和醫護人員服裝）所用紡織品規格的核心要素。除了臨床有效性之外，負責人現在還要求紡織品具備可驗證的耐用性、經受多次洗滌後的穩定性以及與感染預防通訊協定的兼容性。

科學檢驗、永續性、供應鏈韌性、監管監督和數位化採購等多種因素正在改變產品開發和應用的動態。

抗菌醫用紡織品的競爭格局和監管環境正受到多項因素的共同影響而重塑。首先，科學檢驗日益成為產品可接受性的決定性因素。醫院和監管機構都在尋求在受控實驗室和實際環境中獲得的證據，以證明相關處理方法能夠在不影響紡織品性能的前提下降低病原體活菌數量。其次，永續性考量正在影響材料的選擇和後整理處理，推動企業轉向使用低環境影響的纖維和可回收的處理技術，以符合其環境目標。

關稅主導的供應鏈重組和產品差異化正在推動策略採購轉變、近岸外包以及整個價值鏈合規投資的增加。

預計在2025年前後實施的關稅累積效應，正對抗菌醫用紡織品的採購、定價和策略方向產生重大影響。直接影響體現在採購方重新評估供應商組合，他們尋求透過近岸外包、雙重採購和長期合約來降低成本波動。採購團隊正日益將關稅情境納入供應商選擇模型，優先考慮那些能夠展現成本轉嫁透明度和彈性生產能力的合作夥伴。

詳細的細分分析揭示了不同產品、最終用戶、材料、技術、應用和通路的性能預期和採購行為差異

細分市場分析揭示了不同產品線、最終用戶、材料、技術、應用和分銷管道的性能要求和決策標準各不相同。從產品類型來看，床上用品（包括被套、枕頭套和床單）的競爭重點在於耐用性和耐洗滌性。而窗簾（包括淋浴設備和窗簾）則需要具備抗菌功效以及防黴防臭性能。病人服裝（分為罩衣和睡衣）需要親膚布料和舒適的觸感，而醫護人員服裝（包括實驗服和手術服）則更注重性能和防護性，而非耐洗滌性。枕頭套和毛巾必須在吸水性和持久抗菌性之間取得平衡，因此不同產品系列採用了不同的設計和後整理過程。

全球各地在法規、採購重點和製造能力方面的差異，正在塑造全球供應商和醫療保健採購商的差異化策略。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢差異顯著，每個地區都呈現出獨特的監管、臨床和供應方面的特點，這些特點都會影響紡織品策略。在美洲，醫院和長期照護機構高度重視實證技術以及與集中式洗衣系統的營運整合，這迫使供應商優先考慮檢驗的耐用整理處理流程和生命週期文件。此外，由於關稅的不確定性和物流成本，該地區對國內採購和近岸外包也表現出濃厚的興趣。

競爭優勢正逐漸圍繞著技術檢驗、整合服務交付、策略夥伴關係和供應鏈敏捷性而來，而不是單純的成本競爭。

競爭格局的核心在於那些整合了紡織品製造、抗菌處理技術和臨床檢驗能力的公司。市場領導往往會加大研發投入，以提高高效處理的耐久性和耐洗牢度，同時建立強而有力的證據體系來應對監管和臨床方面的挑戰。除了核心產品創新之外，服務差異化，例如認證協助、客製化加工和合約洗滌，能夠加強與客戶的長期關係，並降低客戶轉換。

領導者的實用指南：將顛覆轉化為優勢，重點在於檢驗、在地化生產、永續化學技術、附加價值服務和商業性敏捷性

產業領導者應優先考慮整合技術檢驗、供應鏈韌性、法規準備和以客戶為中心的服務的協作策略。首先，投資強大的實驗室和臨床檢驗項目，以證明產品在洗滌週期和實際使用條件下均能保持持續的抗菌性能，從而增強採購信心並鞏固高階定位。其次，透過發展本地生產和加工能力，並與物流和貿易合規合作夥伴達成應急協議，實現採購多元化，以減輕關稅和海關干擾的影響。

結合結構化專家訪談、監管分析、最後覆核的實驗室檢驗和情境建模等嚴謹的混合方法研究，旨在產生決策層面的策略洞見。

本執行摘要的研究結合了多方面檢驗、專家訪談和應用檢驗，以確保分析的嚴謹性和實際相關性。主要研究包括對採購人員、感染預防專家、紡織工程師和供應鏈高階主管進行結構化訪談，以確定採購重點、臨床檢驗標準和營運限制。次要研究分析了監管文件、已發表的臨床研究、專利申請和公開的行業報告，以繪製技術發展路徑並識別監管趨勢。

將策略需求與注重經檢驗的績效、永續化學、供應鏈韌性和以結果為導向的供應商協作相結合

摘要，抗菌醫用紡織品市場正從實驗階段走向主流採購，其驅動力在於實證實踐、永續性和供應鏈管理。那些將產品開發與嚴格檢驗相結合、投資於具有韌性的本地供應鏈並提供能夠將技術性能轉化為營運價值的服務的企業，將獲得最大的永續優勢。監管審查和關稅趨勢將提高商品化產品的進入門檻，同時也將獎勵那些能夠提供安全性、耐用性和全生命週期性能證明的相關人員。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 透過在外科用紡織品上使用銀奈米顆粒塗層來減少院內感染
  • 將吸濕排汗和抗菌紗線技術應用於醫院床品和製服
  • 推動採用環保整理技術的永續抗菌紡織品生產法規
  • 利用先進的抗菌織物耐久性測試擴大醫院布草再利用項目
  • 增加對紡織品嵌入式感測器的投資，並結合抗菌處理技術用於病患監測

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8.抗菌醫用紡織品市場（依產品分類）

  • 床單
    • 羽絨被套
    • 枕頭套
    • 床單
  • 窗簾
    • 淋浴設備
    • 窗簾
  • 病人服裝
    • 罩衣
    • 睡衣
  • 枕頭套
  • 員工服裝
    • 白大衣
    • 手術服
  • 毛巾

9. 依最終使用者分類的抗菌醫用紡織品市場

  • 門診手術中心
  • 診所
  • 醫院
  • 長期照護機構

第10章：抗菌醫用紡織品市場（依材料分類）

  • 混合
  • 棉布
  • 聚酯纖維

第11章 抗菌醫用紡織品市場（依技術分類）

  • 幾丁聚醣
    • 提取的幾丁聚醣
    • 改質幾丁聚醣
  • 季銨化合物
    • 單烷基季銨化合物
    • 聚合季銨化合物
  • 銀型
    • 離子銀
    • 奈米銀
  • 三氯生
    • 散裝三氯生
    • 微囊化三氯生

第12章 按應用分類的抗菌醫用紡織品市場

  • 急診室
  • 加護病房
  • 手術室
  • 病房

第13章 抗菌醫用紡織品市場（依通路分類）

  • 離線
    • 專賣店
    • 批發商
  • 線上

第14章 抗菌醫用紡織品市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 抗菌醫用紡織品市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國抗菌醫用紡織品市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • BASF SE
    • The Dow Chemical Company
    • Huntsman International LLC
    • Archroma International GmbH
    • Clariant AG
    • Microban International Limited
    • Sanitized AG
    • Polygiene AB
    • BioCote Limited
    • Milliken & Company
Product Code: MRR-81515600A43F

The Antimicrobial Hospital Textiles Market is projected to grow by USD 23.74 billion at a CAGR of 7.50% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 13.30 billion
Estimated Year [2025] USD 14.30 billion
Forecast Year [2032] USD 23.74 billion
CAGR (%) 7.50%

A shifting clinical and procurement paradigm driving widespread adoption of validated antimicrobial textiles across hospital operations and care environments

The hospital textiles environment is undergoing a sustained transformation as clinical safety priorities converge with operational cost pressures and sustainability mandates. Antimicrobial finishes and embedded technologies are no longer experimental add-ons; they are core features of textile specifications used across critical care areas, patient rooms, and staff apparel. Alongside clinical efficacy, buyers now demand demonstrable durability, wash-cycle stability, and compatibility with infection prevention protocols.

In practical terms, procurement teams must reconcile clinical outcomes with lifecycle economics, balancing the upfront costs of treated textiles against reduced contamination risk and potential operational savings. Meanwhile, textile manufacturers and finishers face rising regulatory scrutiny and evolving standards for antimicrobial claims, which intensifies the need for rigorous testing and transparent labeling. As a result, innovation pathways are shifting toward validated technologies, scalable processes, and evidence-based performance claims that integrate seamlessly with hospital laundering and reuse systems.

Consequently, stakeholders across the value chain-from material suppliers and converters to clinicians and environmental services-are realigning priorities. The immediate implication is a stronger emphasis on cross-functional collaboration to ensure that material selection, treatment processes, and clinical practices collectively deliver measurable improvements in patient and staff safety.

Converging forces of scientific validation, sustainability, supply chain resilience, regulatory scrutiny, and digital procurement transforming product development and adoption dynamics

Several convergent shifts are reshaping the competitive and regulatory landscape for antimicrobial hospital textiles. First, scientific validation increasingly determines product acceptance; hospitals and regulators expect controlled laboratory and real-world evidence that treatments reduce viable pathogen load without compromising textile performance. Second, sustainability considerations are influencing material choices and finishing chemistries, prompting a move toward lower-impact fibers and recyclable treatments that align with corporate environmental goals.

Third, supply chain resilience has risen on executive agendas, accelerating efforts to diversify sourcing and localize critical production capabilities to mitigate geopolitical risks and tariff exposures. Fourth, regulatory oversight and standards bodies are scrutinizing certain broad-spectrum actives, which is causing manufacturers to invest in alternative technologies and to document safety profiles more comprehensively. Fifth, digitization and data-driven procurement are enabling hospitals to track textile performance, laundering effects, and clinical correlations, which informs purchasing cycles and total cost of ownership calculations.

Collectively, these shifts create both challenges and opportunities: they raise the bar for market entry while rewarding firms that combine validated antimicrobial efficacy, sustainable production, and responsive supply chain strategies. As market participants adapt, expect increased collaboration between textile chemists, clinical researchers, and procurement specialists to accelerate adoption and to demonstrate measurable benefits in operational settings.

Tariff-driven supply chain reconfiguration and product differentiation forcing strategic sourcing shifts, nearshoring efforts, and elevated compliance investments across the value chain

The cumulative impact of tariff measures implemented in and around 2025 has material consequences for the sourcing, pricing, and strategic orientation of antimicrobial hospital textiles. One immediate effect has been a reappraisal of supplier portfolios as buyers seek to mitigate cost volatility through nearshoring, dual sourcing, and longer contract durations. Procurement teams are increasingly incorporating tariff scenarios into supplier selection models, favoring partners that can demonstrate cost pass-through transparency and flexible production capacity.

Another consequence has been accelerated product rationalization by manufacturers. Faced with higher input costs and customs complexities, firms prioritize higher-margin or technically differentiated lines-such as advanced coating technologies or validated fabric systems-that justify premium pricing. At the same time, some commoditized product lines experience consolidation as smaller suppliers struggle to absorb tariff-related cost increases.

Moreover, compliance and administrative burdens have grown, prompting more firms to invest in trade advisory services, tariff classification audits, and logistics optimizations. These investments can improve margin resilience but also raise operating overhead. In response, forward-looking companies are pursuing partnerships with regional converters, investing in domestic finishing capability, and offering value-added services that strengthen customer relationships and reduce raw-material import dependency. The net effect is a reconfigured supply chain landscape in which agility, transparency, and technical differentiation determine competitive advantage.

A granular segmentation view exposing distinct product, end-user, material, technology, application, and channel-driven performance expectations and procurement behaviors

Segmentation analysis reveals distinct performance drivers and decision criteria across product lines, end users, materials, technologies, applications, and distribution channels. When considering product categories, bed linen-including duvet covers, pillowcases, and sheets-competes on durability and wash-cycle stability, while curtains, encompassing shower and window curtains, require mold and odor resistance in addition to antimicrobial efficacy. Patient apparel, subdivided into gowns and pajamas, demands skin-friendly treatments and comfortable fabric hand, and staff apparel, including lab coats and scrubs, prioritizes repeated laundering performance and protection. Pillow covers and towels must balance absorbency with antimicrobial longevity, creating divergent design and finishing approaches across the product spectrum.

End-user differences between ambulatory surgical centers, clinics, hospitals, and long-term care facilities shape procurement priorities and acceptable cost structures. Ambulatory settings lean toward single-use or lower-cost solutions with rapid turnover characteristics, clinics favor versatile textiles that serve heterogeneous patient populations, hospitals emphasize validated performance for infection control, and long-term care facilities prioritize comfort and durability for prolonged resident use.

Material selection among blends, cotton, and polyester influences both treatment chemistry compatibility and lifecycle considerations. Blends offer performance trade-offs, cotton supports comfort and biodegradability narratives, and polyester brings durability and rapid drying benefits. Technology choices-spanning chitosan with its extracted and modified derivatives, quaternary ammonium compounds split into monoalkyl and polymeric variants, silver-based approaches including ionic and nano forms, and triclosan available as bulk or microencapsulated formats-dictate efficacy profiles, regulatory pathways, and wash-fastness characteristics. Application contexts such as emergency rooms, intensive care units, operating rooms, and patient rooms impose specific performance thresholds and validation requirements. Finally, distribution channels split between offline specialty stores and wholesalers and online platforms, each shaping lead times, minimum order quantities, and the scope for value-added services such as custom finishing or certification documentation.

Regional contrasts in regulation, procurement priorities, and manufacturing capacity shaping differentiated strategies for suppliers and healthcare purchasers worldwide

Regional dynamics vary markedly across the Americas, Europe, Middle East & Africa, and Asia-Pacific, each presenting unique regulatory, clinical, and supply-side characteristics that influence textile strategies. In the Americas, hospitals and long-term care facilities place strong emphasis on evidence-backed technologies and operational integration with centralized laundering systems, prompting suppliers to prioritize validated, durable finishes and lifecycle documentation. The region also exhibits a pronounced interest in domestic sourcing and nearshoring as a response to tariff uncertainty and logistics costs.

Within Europe, Middle East & Africa, regulatory harmonization and sustainability mandates are powerful drivers. Hospitals in this combined region often require compliance with stringent chemical safety standards and increasingly favor treatments that demonstrate reduced environmental impact. Meanwhile, healthcare systems across the Middle East are expanding capacity, which creates demand for scalable suppliers that can meet large institutional contracts.

Asia-Pacific continues to combine large-scale manufacturing capacity with rapid clinical adoption in urban healthcare centers. Procurement in this region balances cost sensitivity with growing expectations for validated antimicrobial performance, particularly in high-acuity settings. Across all regions, digital procurement tools and clinical evidence influence purchasing decisions, while local regulatory shifts and trade policies shape supplier strategies and investment choices.

Competitive advantage consolidating around technical validation, integrated service offerings, strategic partnerships, and supply chain agility rather than pure cost competition

Competitive dynamics center on firms that integrate textile manufacturing, antimicrobial finishing expertise, and clinical validation capabilities. Market leaders tend to invest in R&D to improve the durability and wash-fastness of active treatments while building robust evidence packages that address regulatory and clinical queries. Beyond core product innovation, service differentiation-such as certification support, customized finishing, and contract laundering compatibility-strengthens long-term customer relationships and reduces buyer switching propensity.

Partnerships between fabric producers, chemistry specialists, and independent testing laboratories are increasingly common as companies seek to de-risk claims and accelerate market acceptance. Strategic alliances with healthcare systems and laundries facilitate real-world performance evaluations and create reference accounts that support broader sales efforts. New entrants often focus on niche opportunities, such as biodegradable treatments or application-specific systems for operating rooms and intensive care units, leveraging technical differentiation to gain traction.

Operationally, firms that excel at logistics, tariff navigation, and regional manufacturing presence are better positioned to meet institutional procurement cycles and to absorb supply chain shocks. As a result, competitive advantage aggregates around technical credibility, supply chain agility, and demonstrable clinical outcomes rather than price alone.

Actionable playbook for leaders focusing on validation, regional production, sustainable chemistries, value-added services, and commercial agility to convert disruption into advantage

Industry leaders should prioritize a coordinated strategy that marries technical validation, supply chain resilience, regulatory readiness, and customer-centric services. First, invest in robust laboratory and clinical validation programs that demonstrate sustained antimicrobial performance across laundering cycles and real-world use conditions, thereby strengthening procurement confidence and supporting premium positioning. Second, diversify sourcing by developing regional production or finishing capacity and by establishing contingency agreements with logistics and trade compliance partners to mitigate tariff and customs disruption.

Third, accelerate R&D into lower-environmental-impact chemistries and recyclable materials to address sustainability mandates and to preempt regulatory constraints on specific active substances. Fourth, build value-added services-including certification assistance, training modules for environmental services teams, and data-reporting tools-that tie product performance to operational metrics and help buyers justify investment. Fifth, optimize commercial models across offline and online channels, offering flexible contract terms and scalable trial programs that reduce adoption friction for large institutional purchasers.

Finally, adopt scenario planning and financial stress-testing to evaluate the impact of tariff trends, regulatory changes, and shifts in hospital purchasing practices. By aligning product development, compliance, and go-to-market execution around these strategic pillars, companies can convert market disruption into durable competitive differentiation.

Robust mixed-method research combining structured expert interviews, regulatory analysis, lab validation cross-checks, and scenario modeling to produce decision-grade strategic insights

The research underpinning this executive summary combines multi-source triangulation, expert interviews, and applied validation to ensure analytical rigor and practical relevance. Primary research involved structured interviews with procurement leaders, infection prevention professionals, textile technologists, and supply chain executives to surface buyer priorities, clinical validation criteria, and operational constraints. Secondary research drew from regulatory documents, published clinical studies, patent filings, and publicly available industry reports to map technology pathways and identify regulatory trends.

Analytical methods included cross-validation of claims data with independent laboratory test results, mapping of supply chain dependencies to tariff exposure, and scenario analysis to assess strategic responses to trade policy shifts. Segmentation frameworks were constructed by aligning product attributes, end-user requirements, material properties, and technology performance to produce actionable insight for product development and procurement teams. Throughout the process, methodological safeguards such as source triangulation, conflict-of-interest screening for interviewees, and reproducible analytic workflows were applied to enhance credibility and to support decision-grade recommendations.

Synthesis of strategic imperatives emphasizing validated performance, sustainable chemistries, supply chain resilience, and outcome-focused supplier partnerships

In summary, the antimicrobial hospital textiles landscape is maturing from experimentation to mainstream procurement driven by evidence, sustainability, and supply chain considerations. Stakeholders who align product development with rigorous validation, invest in resilient regional supply chains, and offer services that translate technical performance into operational value will capture the most durable advantage. Regulatory scrutiny and tariff dynamics raise the barrier to entry for commoditized offerings while rewarding firms that can document safety, durability, and lifecycle performance.

Looking ahead, success will depend on the ability to integrate clinical evidence, environmental stewardship, and flexible commercial models that meet the distinct needs of hospitals, ambulatory centers, clinics, and long-term care facilities. Companies that deploy targeted R&D, pursue partnerships for real-world validation, and preempt regulatory changes with safer, more sustainable chemistries will be best positioned to lead. For procurement teams, the imperative is to demand verifiable evidence and to structure supplier relationships that support continuous improvement and operational resilience.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of silver nanoparticle coatings for surgical textiles to reduce hospital acquired infections
  • 5.2. Integration of moisture-wicking and antimicrobial yarn technology in hospital bedding and uniforms
  • 5.3. Regulatory push towards sustainable antimicrobial textile production with ecofriendly finishing techniques
  • 5.4. Growth of hospital linen reuse programs supported by advanced antimicrobial fabric durability testing
  • 5.5. Rising investment in textile embedded sensors coupled with antimicrobial treatments for patient monitoring

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Antimicrobial Hospital Textiles Market, by Product

  • 8.1. Bed Linen
    • 8.1.1. Duvet Covers
    • 8.1.2. Pillowcases
    • 8.1.3. Sheets
  • 8.2. Curtains
    • 8.2.1. Shower Curtains
    • 8.2.2. Window Curtains
  • 8.3. Patient Apparel
    • 8.3.1. Gowns
    • 8.3.2. Pajamas
  • 8.4. Pillow Covers
  • 8.5. Staff Apparel
    • 8.5.1. Lab Coats
    • 8.5.2. Scrubs
  • 8.6. Towels

9. Antimicrobial Hospital Textiles Market, by End User

  • 9.1. Ambulatory Surgical Centers
  • 9.2. Clinics
  • 9.3. Hospitals
  • 9.4. Long Term Care Facilities

10. Antimicrobial Hospital Textiles Market, by Material

  • 10.1. Blends
  • 10.2. Cotton
  • 10.3. Polyester

11. Antimicrobial Hospital Textiles Market, by Technology

  • 11.1. Chitosan
    • 11.1.1. Extracted Chitosan
    • 11.1.2. Modified Chitosan
  • 11.2. Quaternary Ammonium Compounds
    • 11.2.1. Monoalkyl Qac
    • 11.2.2. Polymeric Qac
  • 11.3. Silver Based
    • 11.3.1. Ionic Silver
    • 11.3.2. Nano Silver
  • 11.4. Triclosan
    • 11.4.1. Bulk Triclosan
    • 11.4.2. Microencapsulated Triclosan

12. Antimicrobial Hospital Textiles Market, by Application

  • 12.1. Emergency Rooms
  • 12.2. Intensive Care Units
  • 12.3. Operating Rooms
  • 12.4. Patient Rooms

13. Antimicrobial Hospital Textiles Market, by Distribution Channel

  • 13.1. Offline
    • 13.1.1. Specialty Stores
    • 13.1.2. Wholesalers
  • 13.2. Online

14. Antimicrobial Hospital Textiles Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Antimicrobial Hospital Textiles Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Antimicrobial Hospital Textiles Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. BASF SE
    • 17.3.2. The Dow Chemical Company
    • 17.3.3. Huntsman International LLC
    • 17.3.4. Archroma International GmbH
    • 17.3.5. Clariant AG
    • 17.3.6. Microban International Limited
    • 17.3.7. Sanitized AG
    • 17.3.8. Polygiene AB
    • 17.3.9. BioCote Limited
    • 17.3.10. Milliken & Company

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. ANTIMICROBIAL HOSPITAL TEXTILES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. ANTIMICROBIAL HOSPITAL TEXTILES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ANTIMICROBIAL HOSPITAL TEXTILES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY BED LINEN, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY BED LINEN, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY BED LINEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY BED LINEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY BED LINEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY BED LINEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY BED LINEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY BED LINEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY DUVET COVERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY DUVET COVERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY DUVET COVERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY DUVET COVERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY DUVET COVERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY DUVET COVERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PILLOWCASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PILLOWCASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PILLOWCASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PILLOWCASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PILLOWCASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PILLOWCASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SHEETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SHEETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SHEETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SHEETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SHEETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SHEETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY CURTAINS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY CURTAINS, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY CURTAINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY CURTAINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY CURTAINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY CURTAINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY CURTAINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY CURTAINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SHOWER CURTAINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SHOWER CURTAINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SHOWER CURTAINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SHOWER CURTAINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SHOWER CURTAINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SHOWER CURTAINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY WINDOW CURTAINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY WINDOW CURTAINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY WINDOW CURTAINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY WINDOW CURTAINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY WINDOW CURTAINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY WINDOW CURTAINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PATIENT APPAREL, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PATIENT APPAREL, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PATIENT APPAREL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PATIENT APPAREL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PATIENT APPAREL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PATIENT APPAREL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PATIENT APPAREL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PATIENT APPAREL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY GOWNS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY GOWNS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY GOWNS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY GOWNS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY GOWNS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY GOWNS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PAJAMAS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PAJAMAS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PAJAMAS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PAJAMAS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PAJAMAS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PAJAMAS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PILLOW COVERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PILLOW COVERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PILLOW COVERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PILLOW COVERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PILLOW COVERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PILLOW COVERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY STAFF APPAREL, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY STAFF APPAREL, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY STAFF APPAREL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY STAFF APPAREL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY STAFF APPAREL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY STAFF APPAREL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY STAFF APPAREL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY STAFF APPAREL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY LAB COATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY LAB COATS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY LAB COATS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY LAB COATS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY LAB COATS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY LAB COATS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SCRUBS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SCRUBS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SCRUBS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SCRUBS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SCRUBS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SCRUBS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY TOWELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY TOWELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY TOWELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY TOWELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY TOWELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY TOWELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY LONG TERM CARE FACILITIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY LONG TERM CARE FACILITIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY LONG TERM CARE FACILITIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY LONG TERM CARE FACILITIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY LONG TERM CARE FACILITIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY LONG TERM CARE FACILITIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY BLENDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY BLENDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY BLENDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY BLENDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY BLENDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY BLENDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY COTTON, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY COTTON, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY COTTON, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY COTTON, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY COTTON, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY COTTON, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY POLYESTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY POLYESTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY POLYESTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY POLYESTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY CHITOSAN, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY CHITOSAN, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY CHITOSAN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY CHITOSAN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY CHITOSAN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY CHITOSAN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY CHITOSAN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY CHITOSAN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY EXTRACTED CHITOSAN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY EXTRACTED CHITOSAN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY EXTRACTED CHITOSAN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY EXTRACTED CHITOSAN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY EXTRACTED CHITOSAN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY EXTRACTED CHITOSAN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY MODIFIED CHITOSAN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY MODIFIED CHITOSAN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY MODIFIED CHITOSAN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY MODIFIED CHITOSAN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY MODIFIED CHITOSAN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY MODIFIED CHITOSAN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUNDS, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUNDS, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUNDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUNDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUNDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUNDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUNDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY QUATERNARY AMMONIUM COMPOUNDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY MONOALKYL QAC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY MONOALKYL QAC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY MONOALKYL QAC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY MONOALKYL QAC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY MONOALKYL QAC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY MONOALKYL QAC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY POLYMERIC QAC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY POLYMERIC QAC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY POLYMERIC QAC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY POLYMERIC QAC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY POLYMERIC QAC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY POLYMERIC QAC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SILVER BASED, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SILVER BASED, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SILVER BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SILVER BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SILVER BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SILVER BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SILVER BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SILVER BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY IONIC SILVER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY IONIC SILVER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY IONIC SILVER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY IONIC SILVER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY IONIC SILVER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY IONIC SILVER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY NANO SILVER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY NANO SILVER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY NANO SILVER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY NANO SILVER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY NANO SILVER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY NANO SILVER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY TRICLOSAN, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY TRICLOSAN, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY TRICLOSAN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY TRICLOSAN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY TRICLOSAN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY TRICLOSAN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY TRICLOSAN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY TRICLOSAN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY BULK TRICLOSAN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY BULK TRICLOSAN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY BULK TRICLOSAN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY BULK TRICLOSAN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY BULK TRICLOSAN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY BULK TRICLOSAN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY MICROENCAPSULATED TRICLOSAN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY MICROENCAPSULATED TRICLOSAN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY MICROENCAPSULATED TRICLOSAN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY MICROENCAPSULATED TRICLOSAN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY MICROENCAPSULATED TRICLOSAN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY MICROENCAPSULATED TRICLOSAN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY EMERGENCY ROOMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY EMERGENCY ROOMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY EMERGENCY ROOMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY EMERGENCY ROOMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY EMERGENCY ROOMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY EMERGENCY ROOMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY INTENSIVE CARE UNITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY INTENSIVE CARE UNITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY INTENSIVE CARE UNITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY INTENSIVE CARE UNITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY INTENSIVE CARE UNITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY INTENSIVE CARE UNITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY OPERATING ROOMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY OPERATING ROOMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY OPERATING ROOMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY OPERATING ROOMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY OPERATING ROOMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY OPERATING ROOMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PATIENT ROOMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PATIENT ROOMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PATIENT ROOMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PATIENT ROOMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PATIENT ROOMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY PATIENT ROOMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY OFFLINE, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY OFFLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY OFFLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SPECIALTY STORES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SPECIALTY STORES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SPECIALTY STORES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SPECIALTY STORES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY WHOLESALERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY WHOLESALERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY WHOLESALERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY WHOLESALERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY WHOLESALERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY WHOLESALERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY ONLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY ONLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 289. AMERICAS ANTIMICROBIAL HOSPITAL TEXTILES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 290. AMERICAS ANTIMICROBIAL HOSPITAL TEXTILES MAR